Get started
Author

Michael Pelayo

Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study
2010 · Marilyn L. Kwan, Isaac Joshua Ergas, et al. · Breast Cancer Research and Treatment · 102
Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma.
2018 · Howard Colman, Jeffrey J. Raizer, et al. · Journal of Clinical Oncology · 18
Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394.
2018 · Filip Janku, Ulka N. Vaishampayan, et al. · Journal of Clinical Oncology · 13
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
2024 · Joe S Mendez, Adam L Cohen, et al. · Neuro-Oncology Advances · 11
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PLX9486 alone and in combination (combo) with the KIT inhibitors pexidartinib (pexi) or sunitinib (su) in patients (Pts) with advanced solid tumors and gastrointestinal stromal tumor (GIST).
2018 · Andrew J. Wagner, William D. Tap, et al. · Journal of Clinical Oncology · 9
A phase Ib study of pexidartinib (PLX3397) and weekly paclitaxel in patients with advanced solid tumors including an ovarian cancer subset
2016 · R. Wesolowski, N. Sharma, et al. · Gynecologic Oncology · 4
Actr-20. Initial Results of Plx108-08: an Open Label Phase 1b/2 Study of Orally Administered Pexidartinib (plx3397) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
2016 · Howard Colman, Jeffrey Raizer, et al. · Neuro-Oncology · 3
PDF
Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
2013 · Thach-Giao Truong, Michael Pelayo, et al. · Journal of Clinical Oncology · 3
Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
2013 · Thach-Giao Truong, Michael Pelayo, et al. · Journal of Clinical Oncology
Works count: 9
Citation count: 163
H-index: 5
I10-index: 4
Year
Topic
Type